Global Current Health Expenditure Per Capita by Country

The global current health expenditure per capita remains highest in developed nations, with the United States leading at $14,490, followed by Switzerland at $10,860 and Norway at $9,190. Other top spenders include Luxembourg ($7,940) and Denmark ($7,890). In contrast, countries like Moldova ($347) and Thailand ($339.2) show significantly lower expenditures, reflecting varied resource allocation and healthcare efficiencies across nations.

Notable future trends to watch include the potential impact of aging populations in higher-spending countries, technological advancements in medical treatments driving costs, and healthcare reforms aimed at cost containment. Emerging economies may also see gradual increases in health expenditure driven by economic growth and investment in healthcare infrastructure.

Top countries in Current Health Expenditure Per Capita by Country

# 10 Countries US Dollars Last Year
1 1 United States 14,490 2023 View data
2 2 Switzerland 10,860 2023 View data
3 3 Norway 9,190 2023 View data
4 4 Luxembourg 7,940 2023 View data
5 5 Denmark 7,890 2023 View data
6 6 Sweden 7,350 2023 View data
7 7 Ireland 7,100 2023 View data
8 8 Netherlands 6,950 2023 View data
9 9 Iceland 6,910 2023 View data
10 10 Germany 6,840 2023 View data

Latest reports

 US Autoimmune Disease Market Report- Q1 2025

US Autoimmune Disease Market Report- Q1 2025

The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...

 China Autoimmune Disease Market Report- Q1 2025

China Autoimmune Disease Market Report- Q1 2025

The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...

 Japan Autoimmune Disease Market Report- Q1 2025

Japan Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...

 Germany Autoimmune Disease Market Report- Q4 2024

Germany Autoimmune Disease Market Report- Q4 2024

The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...

 UK Autoimmune Disease Market Report- Q1 2025

UK Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...

 South Korea Autoimmune Disease Market Report- Q1 2025

South Korea Autoimmune Disease Market Report- Q1 2025

The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...

Top Countries about Chronic Disease